MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.135
+0.155 (7.83%)
Apr 24, 2025, 4:00 PM EDT - Market closed
MEI Pharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for MEI Pharma.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for MEI Pharma is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 23, 2024 |
Stifel | Stifel | Hold Maintains $7 | Hold | Maintains | $7 | +227.87% | Apr 12, 2024 |
Stifel | Stifel | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +227.87% | Feb 14, 2024 |
Stifel | Stifel | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +321.55% | Sep 27, 2023 |
Brookline Capital | Brookline Capital | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +3,647.07% | May 23, 2023 |
Financial Forecast
Revenue This Year
n/a
from 65.30M
Revenue Next Year
25.50M
EPS This Year
-6.41
from 2.67
EPS Next Year
-3.78
from -6.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | 26.3M | 26.3M |
Avg | n/a | 25.5M | 25.5M |
Low | n/a | 24.5M | 24.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | 2.9% |
Avg | - | - | - |
Low | - | - | -3.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -6.59 | -3.90 | -1.64 |
Avg | -6.41 | -3.78 | -1.59 |
Low | -6.15 | -3.64 | -1.53 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.